Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04±³À°ÀÏÀÚ : 2021-12-04
±³À°Àå¼Ò : õ¾È ½Å¶ó½ºÅ×ÀÌ
±³À°ÁÖÁ¦ :
Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺ¹¸·¾ÏÇÐȸ
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 041-529-6186
À̸ÞÀÏ :
office@kspsm.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
Ãæû³²µµ±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï: 4¸¸¿ø ÇöÀåµî·Ï: 5¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:10~09:30 Anatomy and physiology of the peritoneum ¾Èżº(¼øõÇâ´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:30~09:50 Peri-operative management to pervent complications À̼ºÃ¶(´Ü±¹´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:50~10:10 Immunological importance in peritoneal surface malignancy ±è¿ì¶÷(Â÷ÀÇ´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 10:10~10:30 Micro-tumor environment changes in advanced and recurrent epithelial ovarian cancer ÀÌÁ¤À±(¿¬¼¼´ë)
ÈÞ½Ä 12-04 ½Å¶ó½ºÅ×ÀÌ 10:30~10:50 Break time ()
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 10:50~11:10 Principles in the treatment of colorectal cancer with peritoneal metastasis ¹é½ÂÇõ(¿¬¼¼´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:10~11:30 Update in PMCR from surgical point of view ¹Ú¼ö¿¬(°æºÏ´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:30~11:50 Update in PMCR from oncological point of view ¹Ú¿µ¼®(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:50~12:10 Update in appendiceal cancer from pathological point of view ÀÌ¿ø¾Ö(´Ü±¹´ë)
½Ä»ç 12-04 ½Å¶ó½ºÅ×ÀÌ 12:10~13:00 Lunch Time ()
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:00~13:30 Future perspective of the CRS/HIPEC as treatment modality for peritoneal surface malignancy ¹Úµ¿±¹(´Ü±¹´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:30~13:50 HIPEC/IP Chemotherapy Treatment Strategy with changing paradigm of molecular/immune therapy in frontline treatment of OC ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:50~14:10 Surgery and HIPEC with changing paractice of melecular/immune therapy in recurrent OC Àå¼®ÁØ(¾ÆÁÖ´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 14:10~14:30 Recent advancement of HIPEC protocols in ovarian cancer ¼Û¿ëÁß(ºÎ»ê´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 14:30~14:50 Novel Clinical trials of HIPEC in peritoneal metastases from gynecologic malignancy Dr. Sonke(Netherlands-¾Ï¼¾ÅÍ)
ÈÞ½Ä 12-04 ½Å¶ó½ºÅ×ÀÌ 14:50~15:10 Break Time ()
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:10~15:30 CT-Based Model to Predict Peritoneal Metastasis from Gastric Cancer Á¤¿ì°æ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:30~15:50 An Innovative Method of Treatment for Peritoneal Carcinomatosis in Gastric Cancer ¹Î»çÈ«(Ãæ³²´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:50~16:10 Intraperitoneal Chemotherapy for Peritoneal Metastasis in Gastric Cancer ±èÁ¾ÇÑ(°í·Á´ë)
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 16:10~16:30 Update of HIPEC(Hyperthermic Intraperitoneal Chemotherapy) for Gastric Cancer Áö¿¹¼·(´Ü±¹´ë)